NIPPON CHEMIPHAR CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,590 JPY | -1.36% |
|
-0.69% | +1.86% |
| 2023 | Delta-Fly Pharma, Inc. announced that it has received ¥503.7238 million in funding from Nippon Chemiphar Co., Ltd. | CI |
| 2023 | Global EV battery supply chain puzzles over China graphite curbs | RE |
ETFs positioned on Nippon Chemiphar Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 15 M€ | +7.34% | ||
| 0.00% | 18 M€ | +16.15% | - | |
| 0.00% | 66,066 M€ | +14.68% | - | |
| 0.00% | 144,586 M€ | +14.49% | ||
| 0.00% | 20,721 M€ | +13.52% | - |
NIPPON CHEMIPHAR CO., LTD. is a Japan-based company centered on ethical pharmaceutical products and mainly engaged in the pharmaceutical, health and beauty related businesses. The Companyâs Pharmaceutical segment is engaged in the manufacture and sale of ethical pharmaceutical products. Other businesses include entrusted safety testing, healthcare and real estate leasing business. The Company mainly operates in Japan and Vietnam.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +1.86% | 36.89M | |
| +25.83% | 661B | |
| +26.47% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +14.72% | 231B | |
| +5.26% | 200B | |
| -8.88% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 4539 Stock
- Funds and ETFs Nippon Chemiphar Co., Ltd.
